2023 Q1 Form 10-K Financial Statement

#000121390023024610 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $15.78M $27.95M $58.95M
YoY Change 28.69% 121.33% 48.49%
Cost Of Revenue $11.08M $14.60M $42.38M
YoY Change 22.57% 63.09% 52.1%
Gross Profit $4.694M $13.35M $16.57M
YoY Change 45.86% 263.21% 39.99%
Gross Profit Margin 29.75% 47.76% 28.11%
Selling, General & Admin $18.03M $24.52M $72.96M
YoY Change 347.96% 522.15% 494.44%
% of Gross Profit 384.05% 183.68% 440.33%
Research & Development $963.0K $1.103M $5.330M
YoY Change -0.58%
% of Gross Profit 20.52% 8.26% 32.17%
Depreciation & Amortization $259.4K $194.0K $725.4K
YoY Change 79.84% 71.36% 62.39%
% of Gross Profit 5.53% 1.45% 4.38%
Operating Expenses $6.079M $25.81M $18.08M
YoY Change 51.06% 555.07% 47.27%
Operating Profit -$1.385M -$12.47M -$1.506M
YoY Change 71.84% 4589.49% 243.86%
Interest Expense $2.620M $10.51M -$9.746M
YoY Change -70341.29% -14990.93% 7031.57%
% of Operating Profit
Other Income/Expense, Net $326.6K -$1.874M $28.07K
YoY Change 275.75% 121.98% -141.41%
Pretax Income -$1.059M -$3.828M -$1.478M
YoY Change 46.44% 832.27% -1256.75%
Income Tax -$364.0K -$914.0K -$699.2K
% Of Pretax Income
Net Earnings -$694.5K -$2.914M -$778.4K
YoY Change 27.25% 9727.99% -430.91%
Net Earnings / Revenue -4.4% -10.43% -1.32%
Basic Earnings Per Share -$0.04 -$0.04
Diluted Earnings Per Share -$0.04 -$0.27 -$0.04
COMMON SHARES
Basic Shares Outstanding 18.32M shares 18.63M shares 19.20M shares
Diluted Shares Outstanding 18.48M shares 19.20M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $617.0K $15.39M $15.39M
YoY Change -98.46% -52.26% -52.26%
Cash & Equivalents $10.60M $15.25M
Short-Term Investments $10.27M $9.780M $9.780M
Other Short-Term Assets $3.810M $2.539M $2.539M
YoY Change 122.83% 126.04% 126.04%
Inventory $5.666M $6.868M $15.73M
Prepaid Expenses
Receivables $11.91M $14.44M $1.578M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $41.52M $48.57M $35.23M
YoY Change -28.05% 2.11% -25.93%
LONG-TERM ASSETS
Property, Plant & Equipment $1.193M $1.000M $18.99M
YoY Change -28.52% 62.4% 1009.89%
Goodwill
YoY Change
Intangibles $5.655M $6.272M
YoY Change 225.1%
Long-Term Investments $6.759M $7.404M $7.404M
YoY Change -97.08% -96.8% -96.8%
Other Assets $1.065M $1.074M $1.074M
YoY Change 1061.78%
Total Long-Term Assets $7.624M $8.057M $39.71M
YoY Change 31.83% 121.35% 990.82%
TOTAL ASSETS
Total Short-Term Assets $41.52M $48.57M $35.23M
Total Long-Term Assets $7.624M $8.057M $39.71M
Total Assets $49.15M $56.63M $74.93M
YoY Change -22.59% 10.59% 46.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.46M $19.61M $19.61M
YoY Change 361.11% 293.4% 293.4%
Accrued Expenses $10.54M $12.14M $12.14M
YoY Change 927.38% 957.97% 957.97%
Deferred Revenue
YoY Change
Short-Term Debt $7.729M $0.00 $0.00
YoY Change 4660.41% -100.0% -100.0%
Long-Term Debt Due $2.170M $1.810M $1.810M
YoY Change 37.96% 171.83%
Total Short-Term Liabilities $8.399M $13.96M $53.72M
YoY Change -55.1% 78.21% 586.01%
LONG-TERM LIABILITIES
Long-Term Debt $56.26M $60.85M $60.85M
YoY Change 3679.39% 6134.33% 6134.33%
Other Long-Term Liabilities $32.62M $32.99M $32.99M
YoY Change 4528.74% 4104.13% 4104.13%
Total Long-Term Liabilities $2.050M $3.306M $93.84M
YoY Change -6.51% 87.76% 5229.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.399M $13.96M $53.72M
Total Long-Term Liabilities $2.050M $3.306M $93.84M
Total Liabilities $10.45M $17.26M $148.0M
YoY Change -50.0% 79.96% 1442.54%
SHAREHOLDERS EQUITY
Retained Earnings $389.0K $1.084M
YoY Change -41.81%
Common Stock $1.849K $1.848K
YoY Change -6.48%
Preferred Stock
YoY Change
Treasury Stock (at cost) $6.668M
YoY Change
Treasury Stock Shares
Shareholders Equity $38.70M $39.36M -$73.02M
YoY Change
Total Liabilities & Shareholders Equity $49.15M $56.63M $74.93M
YoY Change -22.59% 10.59% 46.34%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$694.5K -$2.914M -$778.4K
YoY Change 27.25% 9727.99% -430.91%
Depreciation, Depletion And Amortization $259.4K $194.0K $725.4K
YoY Change 79.84% 71.36% 62.39%
Cash From Operating Activities -$3.592M -$1.301M -$2.414M
YoY Change -150.61% -66.99% -58.62%
INVESTING ACTIVITIES
Capital Expenditures $21.00K -$155.0K $626.3K
YoY Change -103.34% 108.05% -261.03%
Acquisitions
YoY Change
Other Investing Activities $3.000K -$796.0K -$796.0K
YoY Change -99.66%
Cash From Investing Activities -$680.8K -$641.0K -$11.65M
YoY Change 8.43% 760.4% 2894.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.332M
YoY Change -91.58%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$383.9K 0.000 -$2.912M
YoY Change -129.36% -100.0% -107.7%
NET CHANGE
Cash From Operating Activities -$3.592M -1.301M -$2.414M
Cash From Investing Activities -$680.8K -641.0K -$11.65M
Cash From Financing Activities -$383.9K 0.000 -$2.912M
Net Change In Cash -$4.657M -1.942M -$16.97M
YoY Change -159.87% -106.18% -153.75%
FREE CASH FLOW
Cash From Operating Activities -$3.592M -$1.301M -$2.414M
Capital Expenditures $21.00K -$155.0K $626.3K
Free Cash Flow -$3.613M -$1.146M -$3.040M
YoY Change -146.77% -70.37% -44.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41038
CY2022 dei Entity Registrant Name
EntityRegistrantName
STRAN & COMPANY, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3297200
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
2 Heritage Drive
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 600
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Quincy
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02171
CY2022 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
CY2022 dei Trading Symbol
TradingSymbol
SWAG
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
17500160 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18316253 shares
CY2022 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15253756 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32226668 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
9779355 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14442626 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8982768 usd
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
841000 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
113000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
6867564 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
5230792 usd
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
87459 usd
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
87459 usd
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
386884 usd
CY2021Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
623402 usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
910486 usd
CY2021Q4 us-gaap Security Deposit
SecurityDeposit
299411 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
48569130 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
47563500 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1000090 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
615837 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6272205 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1929294 usd
CY2022Q4 strn Right Of Use Asset Office Leases
RightOfUseAssetOfficeLeases
784683 usd
CY2021Q4 strn Right Of Use Asset Office Leases
RightOfUseAssetOfficeLeases
1094778 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
7056888 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
3024072 usd
CY2022Q4 us-gaap Assets
Assets
56626108 usd
CY2021Q4 us-gaap Assets
Assets
51203409 usd
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
1809874 usd
CY2021Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
665855 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
324594 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
310095 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4051657 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4983496 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
608589 usd
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
836915 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
633148 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
721608 usd
CY2022Q4 strn Reward Program Liability
RewardProgramLiability
6000000 usd
CY2021Q4 strn Reward Program Liability
RewardProgramLiability
43878 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
365303 usd
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
106824 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
162358 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
162358 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13955523 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7831029 usd
CY2022Q4 strn Long Term Wildman Contingent Earn Out Liability
LongTermWildmanContingentEarnOutLiability
2845944 usd
CY2021Q4 strn Long Term Wildman Contingent Earn Out Liability
LongTermWildmanContingentEarnOutLiability
976078 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
460089 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
784683 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3306033 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1760761 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18475521 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18475521 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19753852 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19753852 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1848 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1976 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38279151 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39747649 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1083553 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1861994 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
39364552 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41611619 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56626108 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51203409 usd
CY2022 us-gaap Revenues
Revenues
58953467 usd
CY2021 us-gaap Revenues
Revenues
39702714 usd
CY2022 strn Purchases Expenses
PurchasesExpenses
37391939 usd
CY2021 strn Purchases Expenses
PurchasesExpenses
23972797 usd
CY2022 strn Freight Expenses
FreightExpenses
4991854 usd
CY2021 strn Freight Expenses
FreightExpenses
3893847 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
42383793 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
27866644 usd
CY2022 us-gaap Gross Profit
GrossProfit
16569674 usd
CY2021 us-gaap Gross Profit
GrossProfit
11836070 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18075369 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12273949 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
18075369 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
12273949 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1505695 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-437879 usd
CY2022 us-gaap Other Income
OtherIncome
112507 usd
CY2021 us-gaap Other Income
OtherIncome
702280 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
94680 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-136661 usd
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-179120 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28067 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
565619 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1477628 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
127740 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-699187 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-107500 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-778441 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
235240 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19202619 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10928043 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19202619 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21023688 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1627754 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17945151 usd
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1871218 usd
CY2021 strn Stock Issued During Period Value Pipe Stock Issuance Net
StockIssuedDuringPeriodValuePIPEStockIssuanceNet
19779051 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
153205 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
235240 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41611619 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41611619 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1307362 usd
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
225000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
331417 usd
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3332405 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-778441 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
39364552 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-778441 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
235240 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-728000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-113000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
725398 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
446713 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
770062 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
155947 usd
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
63204 usd
CY2022 strn Reduction In Wildman Earn Out Payment
ReductionInWildmanEarnOutPayment
-230328 usd
CY2021 strn Reduction In Wildman Earn Out Payment
ReductionInWildmanEarnOutPayment
69585 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
331417 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
153205 usd
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-179120 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5459858 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3303188 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1636772 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2731743 usd
CY2021 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
87459 usd
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
87473 usd
CY2021 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
500886 usd
CY2022 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-287084 usd
CY2021 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
25516 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-931839 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1715563 usd
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-228326 usd
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-185056 usd
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-231980 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-113019 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
157381 usd
CY2022 us-gaap Increase Decrease In Customer Loyalty Program Liability
IncreaseDecreaseInCustomerLoyaltyProgramLiability
5956122 usd
CY2021 us-gaap Increase Decrease In Customer Loyalty Program Liability
IncreaseDecreaseInCustomerLoyaltyProgramLiability
-129392 usd
CY2022 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
258479 usd
CY2021 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
33814 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2414001 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5291715 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1054776 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
626345 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
388948 usd
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
9965823 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11646944 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-388948 usd
CY2021 strn Note Payable Line Of Credit
NotePayableLineOfCredit
5725000 usd
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
7375000 usd
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
149900 usd
CY2022 strn Contingent Earn Out Liabilities
ContingentEarnOutLiabilities
668731 usd
CY2021 strn Contingent Earn Out Liabilities
ContingentEarnOutLiabilities
542172 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-6748 usd
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
17945151 usd
CY2021 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
19779051 usd
CY2022 strn Net Working Deficit Received In Asset Acquisition
NetWorkingDeficitReceivedInAssetAcquisition
218193 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3332405 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1307362 usd
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1871218 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2911967 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37260096 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16972912 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
31579433 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32226668 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
647235 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15253756 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32226668 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
136661 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
85163 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
360906 usd
CY2022 strn Cost Of Intangible Asset Customer List
CostOfIntangibleAssetCustomerList
640789 usd
CY2022 strn Equipment Acquired In Asset Acquisition
EquipmentAcquiredInAssetAcquisition
-14444 usd
CY2022 us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
626345 usd
CY2022 strn Non Cash Gap Promotions Llc Asset Acquisition
NonCashGAPPromotionsLLCAssetAcquisition
1735000 usd
CY2022 strn Non Cash Trend Inc Asset Acquisition
NonCashTrendIncAssetAcquisition
1470344 usd
CY2022 strn Non Cash Premier Asset Acquisition
NonCashPremierAssetAcquisition
932600 usd
CY2022 us-gaap Stock Issued1
StockIssued1
4137944 usd
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
302929 usd
CY2022 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.08 pure
CY2021 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.04 pure
CY2022 us-gaap Deferred Compensation Arrangement With Individual Maximum Contractual Term1
DeferredCompensationArrangementWithIndividualMaximumContractualTerm1
P24M
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in">8.</td><td style="text-align: justify">Concentration of Credit Risk - Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of accounts receivable and deposits in excess of federally insured limits. These risks are managed by performing ongoing credit evaluations of customers’ financial condition and by maintaining all deposits in high quality financial institutions.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">21.</td><td style="text-align: justify">Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p>
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
9958475 usd
CY2022Q4 strn Unrealized Gain Loss On Investment
UnrealizedGainLossOnInvestment
179120 usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
9779355 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
264160 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6557040 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4124738 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
310524 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1106054 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
6867564 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
5230792 usd
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5664 usd
CY2021Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5664 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
501395 usd
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
410030 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
1525376 usd
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
975952 usd
CY2022Q4 us-gaap Property Plant And Equipment Owned Gross
PropertyPlantAndEquipmentOwnedGross
62424 usd
CY2021Q4 us-gaap Property Plant And Equipment Owned Gross
PropertyPlantAndEquipmentOwnedGross
62424 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2094859 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1454070 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1094769 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
838233 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1000090 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
615837 usd
CY2022Q4 us-gaap Long Term Debt Percentage Bearing Variable Interest Rate
LongTermDebtPercentageBearingVariableInterestRate
0.05 pure
CY2022Q4 strn Cost Of Sale Purchases
CostOfSalePurchases
3571942 usd
CY2021Q4 strn Cost Of Sale Purchases
CostOfSalePurchases
2109427 usd
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
479715 usd
CY2021Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
2874069 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4051657 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4983496 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
7000000 usd
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
7000000 usd
CY2022Q4 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
0 usd
CY2021Q4 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
0 usd
CY2022 us-gaap Deferred Revenue Refund Payments1
DeferredRevenueRefundPayments1
633148 usd
CY2021 us-gaap Deferred Revenue Refund Payments1
DeferredRevenueRefundPayments1
721608 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
721608 usd
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
564227 usd
CY2022 strn Revenue Recognized
RevenueRecognized
-58953467 usd
CY2021 strn Revenue Recognized
RevenueRecognized
-39702714 usd
CY2022 strn Amounts Collected Or Invoiced
AmountsCollectedOrInvoiced
58865007 usd
CY2021 strn Amounts Collected Or Invoiced
AmountsCollectedOrInvoiced
39860095 usd
CY2022 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
633148 usd
CY2021 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
721608 usd
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
6000000 usd
CY2021Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
43878 usd
CY2022Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
162358 usd
CY2022Q4 strn Amount Accrues No Interest
AmountAccruesNoInterest
162358 usd
CY2022Q4 strn Right Of Use Assets
RightOfUseAssets
784683 usd
CY2021Q4 strn Right Of Use Assets
RightOfUseAssets
1094778 usd
CY2022Q4 strn Right Of Use Asset Office Leases Current
RightOfUseAssetOfficeLeasesCurrent
324594 usd
CY2021Q4 strn Right Of Use Asset Office Leases Current
RightOfUseAssetOfficeLeasesCurrent
310095 usd
CY2022Q4 strn Right Of Use Asset Office Leases Non Current
RightOfUseAssetOfficeLeasesNonCurrent
460089 usd
CY2021Q4 strn Right Of Use Asset Office Leases Non Current
RightOfUseAssetOfficeLeasesNonCurrent
784683 usd
CY2022Q4 strn Operating Leases
OperatingLeases
784683 usd
CY2021Q4 strn Operating Leases
OperatingLeases
1094778 usd
CY2022Q4 us-gaap Prepaid Rent
PrepaidRent
456703 usd
CY2021Q4 us-gaap Prepaid Rent
PrepaidRent
388769 usd
CY2022Q4 strn Operating Leases Future Minimum Payment Due Current
OperatingLeasesFutureMinimumPaymentDueCurrent
325250 usd
CY2022Q4 strn Operating Leases Future Minimum Payment Due In Two Years
OperatingLeasesFutureMinimumPaymentDueInTwoYears
322491 usd
CY2022Q4 strn Operating Leases Future Minimum Payment Due In Three Years
OperatingLeasesFutureMinimumPaymentDueInThreeYears
136942 usd
CY2022Q4 strn Operating Lease Future Minimum Payments Due
OperatingLeaseFutureMinimumPaymentsDue
784683 usd
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.02 pure
CY2022 strn Warrants Outstanding
WarrantsOutstanding
4478134 shares
CY2021 strn Warrants Outstanding
WarrantsOutstanding
4749723 shares
CY2021Q4 strn Outstanding Voting Stock Percentage
OutstandingVotingStockPercentage
0.654 pure
CY2022Q1 strn Private Placement Exercise Price
PrivatePlacementExercisePrice
1
CY2021 strn Warrant Exercised
WarrantExercised
0 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
10733651 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.9
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
387867 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
10345784 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.9
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
271589 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.9
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
10074195 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.9
CY2022 strn Weighted Average Life Years Beginning Balance
WeightedAverageLifeYearsBeginningBalance
P5Y
CY2022Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
10000000 usd
CY2022Q4 us-gaap Shares Issued
SharesIssued
1777657 shares
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.87
CY2022 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1777657 shares
CY2022 strn Stock Issued During Periods Value New Issue
StockIssuedDuringPeriodsValueNewIssue
6667595 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
481303 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
168057 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
Option awards are generally granted with an exercise price equal to the fair value of the Company’s stock at the date of grant; those options generally vest based on four years of continuous service and have 10-years contractual terms. 
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0134 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5012 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1587000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.15
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1587000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.15
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
3015300 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
30658 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.15
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
58250 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
68000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.8
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
97000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.11
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1558000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.17
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
453918 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.16
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.8
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4.15
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P10Y
CY2022 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-778441 usd
CY2022 us-gaap Stock Dividends Shares
StockDividendsShares
19202619 shares
CY2021 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
235240 usd
CY2021 us-gaap Stock Dividends Shares
StockDividendsShares
10928043 shares
CY2022 us-gaap Basic Earnings Per Share Adjustment Pro Forma
BasicEarningsPerShareAdjustmentProForma
-0.04
CY2021 us-gaap Basic Earnings Per Share Adjustment Pro Forma
BasicEarningsPerShareAdjustmentProForma
0.02
CY2021 strn Warrants
Warrants
10064987 shares
CY2021 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
30658 usd
CY2022 us-gaap Diluted Earnings Per Share Pro Forma
DilutedEarningsPerShareProForma
-0.04
CY2021 us-gaap Diluted Earnings Per Share Pro Forma
DilutedEarningsPerShareProForma
0.01
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
48282 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-532700 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-76300 usd
CY2022 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-484418 usd
CY2021 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-76300 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-19469 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5500 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-195300 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-36700 usd
CY2022 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
-214769 usd
CY2021 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
-31200 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-699187 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-107500 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
728000 usd
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
113000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
841000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
113000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
375162 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
135436 usd
CY2022 dei Local Phone Number
LocalPhoneNumber
833-3309
CY2022 dei City Area Code
CityAreaCode
800
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
usd
CY2021 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2021 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
usd
CY2022 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
usd
CY2022 strn Note Payable Line Of Credit
NotePayableLineOfCredit
usd
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
usd
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
usd
CY2022 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2022 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
usd
CY2021 strn Net Working Deficit Received In Asset Acquisition
NetWorkingDeficitReceivedInAssetAcquisition
usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 strn Cost Of Intangible Asset Customer List
CostOfIntangibleAssetCustomerList
usd
CY2021 strn Equipment Acquired In Asset Acquisition
EquipmentAcquiredInAssetAcquisition
usd
CY2021 us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
usd
CY2021 strn Non Cash Gap Promotions Llc Asset Acquisition
NonCashGAPPromotionsLLCAssetAcquisition
usd
CY2021 strn Non Cash Trend Inc Asset Acquisition
NonCashTrendIncAssetAcquisition
usd
CY2021 strn Non Cash Premier Asset Acquisition
NonCashPremierAssetAcquisition
usd
CY2021 us-gaap Stock Issued1
StockIssued1
usd
CY2022Q4 strn Operating Leases Future Minimum Payment Due In Four Years
OperatingLeasesFutureMinimumPaymentDueInFourYears
usd
CY2022Q4 strn Operating Leases Future Minimum Payment Due In Five Years
OperatingLeasesFutureMinimumPaymentDueInFiveYears
usd
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2021 strn Weighted Average Life Years Beginning Balance
WeightedAverageLifeYearsBeginningBalance
CY2021 strn Weighted Average Life Years
WeightedAverageLifeYears
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2021 strn Weighted Average Life Years Warrants Exercised
WeightedAverageLifeYearsWarrantsExercised
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022 strn Weighted Average Life Years
WeightedAverageLifeYears
CY2022 strn Weighted Average Life Years Warrants Exercised
WeightedAverageLifeYearsWarrantsExercised
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2021 strn Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted
usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2021 strn Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited Or Expired And Other Adj
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeitedOrExpiredAndOtherAdj
usd
CY2022 strn Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted
usd
CY2022 strn Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited Or Expired And Other Adj
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeitedOrExpiredAndOtherAdj
usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2022 strn Warrants
Warrants
shares
CY2022 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001872525

Files In Submission

Name View Source Status
0001213900-23-024610-index-headers.html Edgar Link pending
0001213900-23-024610-index.html Edgar Link pending
0001213900-23-024610.txt Edgar Link pending
0001213900-23-024610-xbrl.zip Edgar Link pending
f10k2022ex31-1_stranandco.htm Edgar Link pending
f10k2022ex31-2_stranandco.htm Edgar Link pending
f10k2022ex32-1_stranandco.htm Edgar Link pending
f10k2022ex32-2_stranandco.htm Edgar Link pending
f10k2022ex4-1_stranandco.htm Edgar Link pending
f10k2022_stranandcompany.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
f10k2022_stranandcompany_htm.xml Edgar Link completed
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
strn-20221231.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
strn-20221231_cal.xml Edgar Link unprocessable
strn-20221231_def.xml Edgar Link unprocessable
strn-20221231_lab.xml Edgar Link unprocessable
strn-20221231_pre.xml Edgar Link unprocessable